Menu
Back to Journals » Psoriasis: Targets and Therapy » Volume 8
Review
Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,613 | Dovepress* | 9,297+ | 1,376 | 10,673 | |
| PubMed Central* | 2,316 | 416 | 2,732 | ||
| Totals | 11,613 | 1,792 | 13,405 | ||
| *Since 29 August 2018 | |||||
View citations on PubMed Central and Google Scholar